Quantum Blue Drug Monitoring Equipment & Supplies
4 equipment items found
Manufactured by:BÜHLMANN Laboratories AG based inSchönenbuch, SWITZERLAND
The rise of TNFα biologics like infliximab has been a significant step forward to ameliorating disease course and keeping inflammations at remission levels for prolonged periods of time. Patients with too low drug concentrations have worse outcomes than those with adequate drug levels. Therapeutic drug monitoring (TDM) for ...
Manufactured by:BÜHLMANN Laboratories AG based inSchönenbuch, SWITZERLAND
Adalimumab is the first anti TNFα biologic on the market approved for patient self-administration by subcutaneous injections. Patients with suboptimal drug concentrations have worse outcomes than those with adequate drug levels. Therapeutic drug monitoring (TDM) for adalimumab has a great potential for the management of ...
Manufactured by:BÜHLMANN Laboratories AG based inSchönenbuch, SWITZERLAND
The Quantum Blue® Infliximab assay measures from 0.4 to 20 µg/mL. The target concentrations for trough level interpretation lies well within the linear range of the test. Quantum Blue® Infliximab provides a quantitative result within 15 minutes of incubation time. This offers the possibility to health care providers to act immediately before infusion of the next infliximab dose. ...
Manufactured by:BÜHLMANN Laboratories AG based inSchönenbuch, SWITZERLAND
The Quantum Blue® Adalimumab assay measures from 1.3 to 35 µg/ml. The target concentrations for the optimal therapeutic window lies well within the linear range of the test. Quantum Blue® Adalimumab provides a quantitative result within 15 minutes of incubation time. This offers the possibility to health care providers to act immediately while following up the patient’s ...